Based on nucleotide sequence analysis of the hemagglutinin (HA) gene from the virulent and avirulent A/chicken/Pennsylvania/83 influeza viruses, it was previously postulated that acquisition of virulence was associated with a point mutation that resulted in loss of a glycosylation site. Since there are two potential glycosylation sites in this region of the HA molecule and since all Asn-Xaa-Thr/Ser sequences in the HAs of different strains are not necessarily glycosylated, the question remained open as to whether either one of these sites was glycosylated. We now provide direct evidence that a site-specific glycosylation affects cleavage of the influenza virus HA and thus virulence. We have identified the glycosylation sites on the HAl subunit from the virulent and avirulent strains by direct structural analysis of the isolated proteins. Our results show that the only difference in glycosylation between the HAls of the virulent and avirulent strains is the lack of an asparagine-linked carbohydrate on the virulent HAl polypeptide at residue 11. Further, we show that the HAls of both the avirulent and virulent viruses are not glycosylated at one potential site, while all other sites contain carbohydrate. Amino acid sequence analysis of the HAl of an avirulent revertant of the virulent strain confirmed these findings.
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In April 1983, an avirulent (avir) influenza virus, A/chicken/Pennsylvania/1/83 (Chick/Penn) (HSN2), appeared in chickens of eastern Pennsylvania (1) . By October 1983, this virus had become virulent (vir), causing up to 80% mortality in domestic poultry (1, 2) . Gene reassortment studies established that the difference between the viruses was a mutation of the hemagglutinin (HA) (3), a major surface glycoprotein responsible for viral attachment to, and penetration of, host cells. Nucleotide sequencing analysis suggested that the critical mutation eliminated a possible site for the attachment of an N-linked oligosaccharide at Asn-11 of HAl of the avirulent virus by altering a sequence for glycosylation. Preliminary evidence based on molecular weight differences in HAl and growth in the presence of tunicamycin suggested loss of a carbohydrate (4) . However, since not all Asn-XaaSer/Thr sites are glycosylated in different influenza virus HAs, we do not know how many of the potential glycosylation sites contain carbohydrate, and since all of the influenza virus HAs studied to date contain a carbohydrate at this location in the HA molecule (5, 6) , the question of glycosylation at this site remained unresolved.
The HA protein of influenza viruses is post-translationally modified by cleavage at a connecting peptide region into subunits HA1 and HA2 (7) . This cleavage is a prerequisite for viral infectivity (8) , and a correlation has been drawn between HA cleavage and virus production in tissue culture and the virulence of the strain (9) (10) (11) . Although exogenously added trypsin can cleave the HA and permit infectivity in vitro, the mechanism by which HA is processed and cleaved in vivo is unknown.
To determine if altered glycosylation of the Chick/Penn HA was sufficient to explain the differences between the avirulent and virulent strains, we (15) or by fluorescent protein assay with bovine serum albumin as standard (16 (18) . The phenylthiohydantoin derivatives of aspartic and glutamic residues were identified directly as their methyl esters. Total net yields were calculated for each cycle, after correction for background and lag values, which were usually less than 1%. Repetitive yields were calculated by linear regression analysis of all cycles except those yielding serine, threonine, histidine, and cysteine.
RESULTS
The HA1 Protein of the Avirulent Strain Is More Extensively Glycosylated than Is HA1 of the Virulent Strain. Chick/Penn HA1 (avir) has a slower mobility than does the HA1 (vir) when compared by NaDodSO4/PAGE (4). This difference, equivalent to approximately 3 kDa, is illustrated in Fig. 1 , which shows the purified HA1 proteins of the avirulent and virulent strains in lanes 2 and 4, respectively. Digestion with N-glycanase eliminated this difference in mobility (Fig. 1 , lanes 1 and 3), strongly suggesting that these HA1 forms differ by the number of N-linked oligosaccharide chains. The minor difference in mobility between the polypeptides deglycosylated with N-glycanase is due to a net charge difference of 2 units between these molecules. These charge differences lead to anomalous mobility on NaDodSO4 gels (V.A.F., unpublished results). glycosylated Asn to an Asp residue at that position in the sequence (19) . The amino-terminal sequences demonstrated that neither Asn-10 nor Asn-11 is glycosylated on the HAl (vir) protein, since Asn was recovered at both positions. In contrast, Asp was recovered only at position 11 in HAl (avir), demonstrating that this position is glycosylated. Amino-terminal sequence analysis of the glycosylated HAl proteins confirmed this result, since both Asn residues were recovered in the sequence ofthe virulent strain, whereas only a single Asn was recovered at position 10 for the avirulent strain and no residue was released at position 11 (data not shown). Glycosylated residues are not detected directly in sequence analyses. This analysis directly demonstrates that the mutation at position 13 of HA1 (vir) from Thr to Lys eliminates the functional glycosylation site at Asn-11 of HAl (avir). Furthermore, the presence of Asn at position 10 in the HA protein of both the virulent and avirulent strains demonstrates that the sequence at residues 10-12, Asn-Asn-Ser, is not a glycosylation site for either strain.
Glycosylation Time, min deglycosylated peptides. Differences observed between the glycosylated and deglycosylated digests for each HAl protein should reflect only those peptides whose mobility has been altered by removal of the carbohydrate and the concomitant change of the asparagine to aspartate; peptides whose mobility is not altered by deglycosylation are those not containing asparagine-linked carbohydrate. The glycopeptides appear as broad heterogeneous peaks, whereas the deglycosylated peptides are in sharp and well-resolved peaks.
After deglycosylation, 10 new peptides appear that are common to digests of HAl (vir) and HA1 (avir), as can be seen in the direct comparison maps (Fig. 2D) . These peptides are indicated by arabic numerals. Direct amino-terminal sequence analysis of these peptides identified which glycosylation sites were represented. Sufficient sequence information was obtained to identify these peptides (Table 2) , which represent all predicted N-glycosylation sites in HA1 and demonstrate that all these potential glycosylation sites are used in both HAl (vir) and HAl (avir). The (vir) (Fig. 2 A and C) . In addition, a deglycosylated peptide, designated C, is present in the digests of HA1 (avir) but not in HAl (vir) (Fig. 2 A and D) . Direct sequence analysis of peptide C demonstrated that the peptide is glycosylated at Asn-11 (Table 2 ) and, thus, is the only glycopeptide difference between HA1 (vir) and HA1 (avir). Conversely, a nonglycosylated peptide, peptide B, is present in HAl (vir) but not in HAl (avir) (Fig. 2 B, D, and C) . Amino-terminal sequence analysis of peptide B (Table 2 ) demonstrated that it is the predicted amino-terminal peptide of HA1 (vir) that was not glycosylated at either Asn-10 or Asn-11, which confirmed the direct amino-terminal sequence analysis.
Finally, there were two differences in digests of HA1 (vir) and HAl (avir) that are not a function of glycosylation. One of the differences is between peptides D and D'. Peptide D of HAl (avir) contains the second mutation at position 123, from alanine to threonine, that was predicted by nucleotide sequencing ( Table 2 ). The other difference illustrated in Fig. 2 C and D is between peptides E and E' for the HA1 (avir) and HAl (vir), respectively. Peptide E of HAl (avir) elutes earlier than E' of HA1 (vir) and forms a shoulder on the glycopeptide 9 peak. Direct amino-terminal sequence analysis of peptides E and E' demonstrated that they contain the third mutation that distinguishes HA1 (avir) from HAl (vir), respectively, from glutamate to aspartate at position 69 in the sequence (Table 2) . Thus, our analyses have identified all the mutations that distinguish HAl (vir) from HAl (avir) and show that the only direct effect of these changes on glycosylation is the lack of N-linked oligosaccharide to the asparagine at position 11 in HA1 (vir). The peptide analysis also established that corrections to the nucleotide-derived sequence are necessary; Val-61 is replaced by Leu and Val-282 is replaced by Gly.
The Asparagine Residue at Position 11 Is Glycosylated in an Avirulent Revertant of a Virulent Virus. An avirulent revertant of the virulent virus, which no longer has a cleaved HA without trypsin, has an HAl gene sequence that differs from that of its parent by a single point mutation, resulting in a predicted amino acid change at residue 13 (3). This change, from lysine to threonine, caused reversion to a sequence containing a potential glycosylation site previously predicted for the avirulent virus (4 (9, 10) . Presumably, FPV HA processing occurs through an alternative mechanism.
It has been proposed that cleavage of the FPV HA depends on the presence of several consecutive basic amino acids at the cleavage site in the connecting peptide region between HA1 and HA2 (27, 28 Glycosylation of the influenza virus HA is important for protection against proteolytic degradation (29, 30) and for antigenic recognition (31) , and its importance for stabilization of HA conformation and subunit interaction (32) 
